TAT-11: Capabilities of JSC "SSC RIAR" in Producing TH227

Ottawa, ON, Canada (UroToday.com) Mr. Butkaliuk described Th227 production at the Joint Stock Company-"State Scientific Center-Research Institute of Atomic Reactors, JSC "SSC RIAR". First Ra226 targets are exposed to a reactor for 20-25 days to produce Th227 and Ac227. The Thorium and Ac are separated by repeated passes through anion-exchange resin columns.

The separated Ac227 can then be used as a generator to produce both Th227 and Ra223. Residual Ac227 contamination is a problem for using these isotopes in therapy.


Presented by: Mr. Pavel Butkaliuk, Joint Stock Company-State Scientific Center-Research Institute of Atomic Reactors











E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe